We have developed a novel fluorescent Oxygen BioSensor technology platform adaptable to many applications in the area of drug discovery and development, particularly cell-based assays. This biosensor technology requires no additional reagents or incubations, and affords continuous real-time readout of dissolved oxygen concentrations. Since the level of oxygen dissolved in an assay's medium correlates to the number and viability of the cells in the medium, this technology is ideally suited for monitoring cell viability, proliferation, or death. The technology is particularly well suited to investigating cells' kinetic responses to proliferative or toxic stimuli, such as drugs. When incorporated into a 96- or 384-well microplate format, it is compatible with standard laboratory automation systems. Here we present data illustrating the application of the Oxygen BioSensor technology for rapid, homogeneous detection and evaluation of metabolic activity of a variety of eukaryotic and prokaryotic cells, including mammalian cells, insect cells, yeast, and bacteria. In the absence of toxic substances, we find a good correlation between cell number and signal over a wide range of cell concentrations and growth times.
To evaluate the usefulness of the Oxygen BioSensor for cytotoxicity assays, we have performed a series of experiments using a range of toxic agents and cell types, including both bacteria and mammalian cell lines. In a side-by-side comparison to standard MTT assays using HL60 cells, comparable IC50 values were found with the Oxygen BioSensor for five different toxins or drugs. This assay method does not have the need for additional reagents, handling steps, or incubation periods required by the MTT assays.
References
1.
Marshall, E.S., Holdaway, K.M., Shaw, J.H., Finlay, G.J., Matthews, J.H., Baguley, B.C. (1993). Anticancer drug sensitivity profiles of new and established melanoma cell lines. Oncol. Res.5:301-309.
2.
Ahmed, S.A., Gogal, R.M. Jr., Walsh, J.E. (1994). A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: An alternative to [3H] thymidine incorporation assay. J. Immunol. Methods170:211-224.
3.
Mosmann, T. (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods65:55-63.
4.
Desnottes, J.-F. (1996). New targets and strategies for the development of antibacterial agents. Trends Biotech.14:134-140.
5.
Koch, A.L. (1994). Growth measurement. In Methods for General and Molecular Microbiology. P. Gerhardt, R.G.E. Murray, W.A. Wood, and N.R. Krieg (eds.), pp. 248-277. American Society for Microbiology, Washington, DC.
6.
Bacon, J.R., Demas, J.N. (1987). Determination of oxygen concentrations by luminescence quenching of a polymer-immobilized transition-metal complex. Anal. Chem.59:2780-2785.
7.
Watts, R.J., Crosby, G. A. (1971). Spectroscopic characterization of complexes of ruthenium (II) and iridium (III) with 4,4′-diphenyl-2,-2′-bipyridine and 4,7-diphenyl-1,10-phenanthroline. J. Am. Chem. Soc.93:3184-3188.
8.
NCCLS Approved Standard M7-A4: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, 4th ed. (1997). National Committee for Clinical Laboratory Standards, Villanova, PA.
9.
Goodman, A.G., Rall, T.W., Nies, A.S., Taylor, P. (1990). Goodman & Gilman's The Pharmacological Basis of Therapeutics, 8th ed.Pergamon Press, New York.
